Pyk2 mediates endothelin-1 signaling via p130Cas/BCAR3 cascade and regulates human glomerular mesangial cell adhesion and spreading

Journal of Cellular Physiology

Volumn 219, Issue 1, 2009, Pages 45-56

  Rufanova, Victoriya A ^a   Alexanian, Anna ^a   Wakatsuki, Tetsuro ^b   Lerner, Adam ^c,d   Sorokin, Andrey ^a,b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CRK ASSOCIATED SUBSTRATE PROTEIN; ENDOTHELIN 1; FOCAL ADHESION KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; RAP1 PROTEIN; RAS PROTEIN; SMALL INTERFERING RNA; BCAR1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; AUTOPHOSPHORYLATION; CELL ADHESION; CELL SPREADING; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; DOWNSTREAM PROCESSING; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; MESANGIUM CELL; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; CYTOLOGY; ENZYME ACTIVATION; GENE VECTOR; GENETICS; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

ADENOVIRIDAE;

ANIMALS; CELL ADHESION; CELLS, CULTURED; CRK-ASSOCIATED SUBSTRATE PROTEIN; ENDOTHELIN-1; ENZYME ACTIVATION; FOCAL ADHESION KINASE 2; GENETIC VECTORS; GUANINE NUCLEOTIDE-RELEASING FACTOR 2; HUMANS; MESANGIAL CELLS; RAP1 GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 60849124225     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21649     Document Type: Article

References (69)

1. Avraham S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE. 1995. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem 270:27742-27751.
2. Avraham H, Park SY, Schinkmann K, Avraham S. 2000. RAFTK/Pyk2-mediated cellular signalling. Cell Signal 12:123-133.
3. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC. 1989. Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest 83:336-342.
4. Bos JL. 2005. Linking Rap to cell adhesion. Curr Opin Cell Biol 17:123-128.
5. Buensuceso CS, O'Toole TE. 2000. The association of CRKII with C3G can be regulated by integrins and defines a novel means to regulate the mitogen-activated protein kinases. J Biol Chem 275:13118-13125.
6. Cai D, Clayton LK, Smolyar A, Lerner A. 1999. AND-34, a novel p130Cas-binding thymic stromal cell protein regulated by adhesion and inflammatory cytokines. J Immunol 163:2104-2112.
7. Cai D, Felekkis KN, Near RI, O'Neill GM, van Seventer JM, Golemis EA, Lerner A. 2003a. The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42. J Immunol 170:969-978.
8. Cai D, Iyer A, Felekkis KN, Near RI, Luo Z, Chernoff J, Albanese C, Pestell RG, Lerner A. 2003b. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cancer Res 63:6802-6808.
9. Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N, Endlich K. 2003. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol 14:37-45.
10. Cazaubon S, Chaverot N, Romero IA, Girault JA, Adamson P, Strosberg AD, Couraud PO. 1997. Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways. J Neurosci 17:6203-6212.
11. Chellaiah MA, Kuppuswamy D, Lasky L, Linder S. 2007. Phosphorylation of a Wiscott-Aldrich syndrome protein-associated signal complex is critical in osteoclast bone resorption. J Biol Chem 282:10104-10116.
12. Chen Y, Sun Y, Lin J, Zhou A, Wang H. 1997. Research on the mechanism of endothelin inflammatory effects on human mesangial cells. Chin Med J (Engl) 110:530-534.
13. Defilippi P, Olivo C, Venturino M, Dolce L, Silengo L, Tarone G. 1999. Actin cytoskeleton organization in response to integrin-mediated adhesion. Microsc Res Tech 47:67-78.
14. Du QS, Ren XR, Xie Y, Wang Q, Mei L, Xiong WC. 2001. Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK. J Cell Sci 114:2977-2987.
15. Earp HS, Huckle WR, Dawson TL, Li X, Graves LM, Dy R. 1995. Angiotensin II activates at least two tyrosine kinases in rat liver epithelial cells. Separation of the major calcium-regulated tyrosine kinase from p125FAK. J Biol Chem 270:28440-28447.
16. Felekkis KN, Narsimhan RP, Near R, Castro AF, Zheng Y, Quilliam LA, Lerner A. 2005. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner. Mol Cancer Res 3:32-41.
17. Foschi M, Chari S, Dunn MJ, Sorokin A. 1997. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol3-kinase. EMBO J 16:6439-6451.
18. Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, Neff L, Sanjay A, Bruzzaniti A, De Camilli P, Baron R, Schlessinger J. 2007. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(/) mice. J Cell Biol 178:1053-1064.
19. Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, Egido J. 1996. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27:885-892.
20. Gotoh T, Cai D, Tian X, Feig LA, Lerner A. 2000. p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor. J Biol Chem 275:30118-30123.
21. Gupta S, Clarkson MR, Duggan J, Brady HR. 2000. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58:1389-1399. Herman WH, Emancipator SN, Rhoten RL, Simonson MS. 1998. Vascular and glomerular expression of endothelin-1 in normal human kidney. Am J Physiol 275:F8-F17.
22. Herzog H, Nicholl J, Hort YJ, Sutherland GR, Shine J. 1996. Molecular cloning and assignment of FAK2, a novel human focal adhesion kinase, to 8p11.2-p22 by nonisotopic in situ hybridization. Genomics 32:484-486.
23. Ichiba T, Hashimoto Y, Nakaya M, Kuraishi Y, Tanaka S, Kurata T, Mochizuki N, Matsuda M. 1999. Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504. J Biol Chem 274:14376-14381.
24. Imamura T, Huang J, Dalle S, Ugi S, Usui I, Luttrell LM, Miller WE, Lefkowitz RJ, Olefsky JM. 2001. Beta-arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem 276:43663-43667.
25. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248.
26. Kirsch KH, Georgescu MM, Hanafusa H. 1998. Direct binding of p130(Cas) to the guanine nucleotide exchange factor C3G. J Biol Chem 273:25673-25679.
27. Kodama H, Fukuda K, Takahashi E, Tahara S, Tomita Y, Ieda M, Kimura K, Owada KM, Vuori K, Ogawa S. 2003. Selective involvement of p130Cas/Crk/Pyk2/c- Src in endothelin-1-induced JNK activation. Hypertension 41:1372-1379.
28. Kooistra MR, Dube N, Bos JL. 2007. Rap1: A key regulator in cell-cell junction formation. J Cell Sci 120:17-22.
29. Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B,Schlessinger J. 1995. Protein tyrosine kinase PYK2 involved in Ca(2&Thorn)-induced regulation of ion channel and MAP kinase functions. Nature 376:737-745.
30. Levin ER. 1996. Endothelins as cardiovascular peptides. Am J Nephrol 16:246-251.
31. Loeser RF, Forsyth CB, Samarel AM, Im HJ. 2003. Fibronectin fragment activation of proline- rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 278: 24577-24585.
32. Martinez MC, Randriamboavonjy V, Ohlmann P, Komas N, Duarte J, Schneider F, Stoclet JC, Andriantsitohaina R. 2000. Involvement of protein kinase C, tyrosine kinases, and Rho kinase in Ca(2&Thorn) handling of human small arteries. Am J Physiol Heart Circ Physiol 279:H1228-H1238.
33. McLeod SJ, Shum AJ, Lee RL, Takei F, Gold MR. 2004. The Rap GTPases regulate integrin- mediated adhesion, cell spreading, actin polymerization, and Pyk2 tyrosine phosphorylation in B lymphocytes. J Biol Chem 279:12009-12019.
34. Mene P, Simonson MS, Dunn MJ. 1989. Physiology of the mesangial cell. Physiol Rev 69:1347-1424.
35. Murasawa S, Matsubara H, Mori Y, Masaki H, Tsutsumi Y, Shibasaki Y, Kitabayashi I, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Iba S, Iwasaka T. 2000. Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase. J Biol Chem 275:26856-26863.
36. Near RI, Zhang Y, Makkinje A, Vanden Borre P, Lerner A. 2007. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology. J Cell Physiol 212:655-665.
37. Okigaki M, Davis C, FalascaM, Harroch S, Felsenfeld DP, Sheetz MP, SchlessingerJ. 2003. Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc Natl Acad Sci USA 100:10740-10745.
38. Orth SR, Amann K, Gehlen F, Unger L, Wagner J, Raschack M, Ritz E. 2000. Adult human mesangial cells (HMCs) express endothelin-B-receptors which mediate endothelin-1-induced cell growth. J Cardiovasc Pharmacol 36:S232-S237.
39. Ostergaard HL, Lysechko TL. 2005. Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function. Immunol Res 31:267-282.
40. Park SY, Avraham HK, Avraham S. 2004. RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner. J Biol Chem 279:33315-33322.
41. Pratt PF, Bokemeyer D, Foschi M, Sorokin A, Dunn MJ. 2003. Alterations in subcellular localization of p38 MAPK potentiates endothelin-stimulated COX-2 expression in glomerular mesangial cells. J Biol Chem 278:51928-51936.
42. Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD, Schwartz MA. 2000. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci 113:3673-3678.
43. Ren XR, Du QS, Huang YZ, Ao SZ, Mei L, Xiong WC. 2001. Regulation of CDC42 GTPase by proline-rich tyrosine kinase 2 interacting with PSGAP, a novel pleckstrin homology and Src homology 3 domain containing rhoGAP protein. J Cell Biol 152:971-984.
44. Rodriguez-Fernandez JL, Sanchez-Martin L, Rey M, Vicente-Manzanares M, Narumiya S, Teixido J, Sanchez-Madrid F, Cabanas C. 2001. Rho and Rho-associated kinase modulate the tyrosine kinase PYK2 in T-cells through regulation of the activity of the integrin LFA-1. J Biol Chem 276:40518-40527.
45. Ruest PJ, Shin NY, Polte TR, Zhang X, Hanks SK. 2001. Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src. Mol Cell Biol 21:7641-7652.
46. Rufanova VA, Sorokin A. 2006. CrkII associates with BCAR3 in response to endothelin-1 in human glomerular mesangial cells. Exp Biol Med (Maywood) 231:752-756.
47. Rufanova VA, Lianos E, Alexanian A, Sorokina E, Sharma M, McGinty A, Sorokin A. 2008. C3G overexpressionin glomerularepithelial cells during anti-GBM-inducedglomerulonephritis. Kidney Int (in press).
48. Ruiz-Torres MP, Lopez-Ongil S, Griera M, Diez-Marques ML, Rodriguez-Puyol M, Rodriguez-Puyol D. 2005. The accumulation of extracellular matrix in the kidney: Consequences on cellular function. J Nephrol 18:334-340.
49. Sakakibara A, Ohba Y, Kurokawa K, Matsuda M, Hattori S. 2002. Novel function of Chat in controlling cell adhesion via Cas-Crk-C3G-pathway-mediated Rap1 activation. J Cell Sci 115:4915-4924.
50. Sasaki H, Nagura K, Ishino M, Tobioka H, Kotani K, Sasaki T. 1995. Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem 270:21206-21219.
51. Satoh K, Ichihara K, Landon EJ, Inagami T, Tang H. 2001. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelial cells. Involvement of geranylgeranylation of small G protein Rap1. J Biol Chem 276:15761-15767.
52. Sawada Y, Nakamura K, Doi K, Takeda K, Tobiume K, Saitoh M, Morita K, Komuro I, De Vos K, Sheetz M, Ichijo H. 2001. Rap1 is involved in cell stretching modulation of p38 but not ERK or JNK MAP kinase. J Cell Sci 114:1221-1227.
53. Sawada Y, Tamada M, Dubin-Thaler BJ, Cherniavskaya O, Sakai R, Tanaka S, Sheetz MP. 2006. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127:1015-1026.
54. Simonson MS, Rooney A. 1994. Characterization of endothelin receptors in mesangial cells: Evidence for two functionally distinct endothelin binding sites. Mol Pharmacol 46:41-50.
55. Simonson MS, Wann S, Mene P, Dubyak GR, Kester M, Nakazato Y, Sedor JR, Dunn MJ. 1989.
56. Endothelin stimulates phospholipase C, Na&Thorn/H&Thorn exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83:708-712.
57. Sorokin A, Kohan DE. 2003. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 285:F579-F589.
58. Sorokin A, Kozlowski P, Graves L, Philip A. 2001. Protein-tyrosine kinase Pyk2 mediates endothelin-induced p38 MAPK activation in glomerular mesangial cells. J Biol Chem 276:21521-21528.
59. Sorokin A, Foschi M, Dunn MJ. 2002. Endothelin signalling and regulation of protein kinases in glomerular mesangial cells. Clin Sci (Lond) 103:132S-136S.
60. Sraer JD, Delarue F, Hagege J, Feunteun J, Pinet F, Nguyen G, Rondeau E. 1996. Stable cell lines of T-SV40 immortalized human glomerular mesangial cells. Kidney Int 49:267-270.
61. Stork PJ. 2003. Does Rap1 deserve a bad Rap? Trends Biochem Sci 28:267-275.
62. Takeda M, Breyer MD, Noland TD, Homma T, Hoover RL, Inagami T, Kon V. 1992. Endothelin-1 receptor antagonist: Effects on endothelin- and cyclosporine-treated mesangial cells. Kidney Int 41:1713-1719.
63. Tamada M, Sheetz MP, Sawada Y. 2004. Activation of a signaling cascade by cytoskeleton stretch. Dev Cell 7:709-718.
64. Tolloczko B, Tao FC, Zacour ME, Martin JG. 2000. Tyrosine kinase-dependent calcium signaling in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 278:L1138-L1145.
65. Wakatsuki T, Wysolmerski RB, Elson EL. 2003. Mechanics of cell spreading: Role of myosin II. J Cell Sci 116:1617-1625.
66. Wang Y, Mishra R, Simonson MS. 2003. Ca(2&Thorn)/calmodulin-dependent protein kinase II stimulates c-fos transcription and DNA synthesis by a Src-based mechanism in glomerular mesangial cells. J Am Soc Nephrol 14:28-36.
67. Watts SW. 2000. 5-Hydroxytryptamine-induced potentiation of endothelin-1-and norepinephrine-induced contraction is mitogen-activated protein kinase pathway dependent. Hypertension 35:244-248.
68. Yajnik V, Paulding C, Sordella R, McClatchey AI, Saito M, Wahrer DC, Reynolds P, Bell DW, Lake R, van den HS, SettlemanJ, Haber DA. 2003. DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell 112:673-684.
69. Zubkov AY, Rollins KS, Parent AD, Zhang J, Bryan RM, Jr. 2000. Mechanism of endothelin-1-induced contraction in rabbit basilar artery. Stroke 31:526-533.